Structure of Human CD272/BTLA HEK293T Stable Cell Line
Human CD272/BTLA HEK293T Stable Cell Line is a genetically modified cell line that expresses the human CD272/BTLA gene. This gene encodes for a transmembrane protein known as B and T lymphocyte attenuator (BTLA), which is a member of the immunoglobulin superfamily. The BTLA protein is composed of an extracellular domain, a transmembrane domain, and a cytoplasmic domain.
The extracellular domain of BTLA contains two immunoglobulin-like domains, IgV and IgC, which are responsible for binding to its ligand, herpes virus entry mediator (HVEM). The transmembrane domain anchors the protein to the cell membrane, while the cytoplasmic domain contains signaling motifs that regulate the activity of BTLA.
Activity of Human CD272/BTLA HEK293T Stable Cell Line
The main function of BTLA is to regulate the immune response by inhibiting the activation of T cells. When BTLA binds to its ligand, HVEM, it initiates a signaling cascade that leads to the suppression of T cell activation. This mechanism is important in maintaining immune homeostasis and preventing excessive immune responses.
In addition to its role in regulating T cell activation, BTLA has also been found to play a role in other immune processes such as regulating B cell activation and promoting the differentiation of regulatory T cells. BTLA has also been shown to have anti-inflammatory effects, making it a potential therapeutic target for autoimmune diseases.
Application of Human CD272/BTLA HEK293T Stable Cell Line
The Human CD272/BTLA HEK293T Stable Cell Line has been widely used in research studies to investigate the role of BTLA in immune regulation. This cell line can be used for various applications, including flow cytometry, to study the expression and function of BTLA.
Flow cytometry is a powerful technique that allows for the analysis of individual cells based on their physical and chemical characteristics. The Human CD272/BTLA HEK293T Stable Cell Line can be labeled with fluorescent antibodies specific to BTLA, allowing for the identification and quantification of BTLA-expressing cells. This technique can be used to study the expression of BTLA in different cell types and under various conditions.
Furthermore, the Human CD272/BTLA HEK293T Stable Cell Line can be used to investigate the therapeutic potential of targeting BTLA. By studying the effects of BTLA inhibition or activation on immune responses, researchers can gain a better understanding of its role in disease and potentially develop novel treatments for immune-related disorders.
In conclusion, the Human CD272/BTLA HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and application of BTLA in immune regulation. Its use in flow cytometry and other research applications has contributed to our understanding of this important protein and its potential as a therapeutic target.
There are no reviews yet.